在极度早产的新生儿中,帕拉西他的度和动脉管径的时间过程:种群的药理动力学分析
Faheemah Padavia1,2, Jean-Marc Treluyer3,4,5,6, Gilles Cambonie7,8
1Université Paris Cité, Inserm, Pharmacologie et évaluation des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. faheemah.padavia@aphp.fr.
Clinical pharmacokinetics
|September 1, 2025
概括
在极度早产的婴儿中,静脉注射的甲醇有效地关闭了动脉通道. 较高的初始剂量加快了管道的关闭,为NSAIDs提供了潜在的更安全的替代品.
科学领域:
- 新生儿药理学
- 儿童心脏病学
- 药量测量
背景情况:
- 在极度早产的婴儿中, 脉动管 (PDA) 是一个常见的并发症.
- 目前的治疗方法,如印梅他辛和易布洛芬, 没有降低死亡率或发病率.
- 降醇是一种潜在的更安全的预防治疗选择.
研究的目的:
- 开发一种药理动力学 (PKPD) 模型,用于静脉注射的类药对动脉管径的影响.
- 在极度早产的新生儿中评估不同类型的青的疗效.
主要方法:
- 一个PKPD模型是使用带有效果区的IMAX模型构建的.
- 极度早产的新生儿 (怀孕23至26周) 接受了预防性静脉注射类药物5天.
- 在500名虚拟患者中模拟PKPD度.
主要成果:
- 鉴定出两个具有明显最大抑制值 (Imax) 的亚群 (99% 和 42%).
- 吸入氧气和通风的部分影响了传输速率常数 (ke0).
- 较高的甲剂量 (25 mg/ kg加重, 10 mg/ kg维持) 实现了95%的最大抑制速度,超过90%的患者在第一天达到值.
结论:
- 一个PKPD模型有效地描述了对极度早产新生儿的血管管径的影响.
- 静脉注射类降解剂,特别是25毫克/千克的加重剂量,然后每6小时注射10毫克/千克,可以加速导管的关闭.
- 超过该疗程的剂量增加提供了有限的额外益处.
相关概念视频
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
194
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
194
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382


